Telix Pharmaceuticals Limited (TLX.AX)
AUD 25.67
(-0.27%)
AUD 25.67
(-0.27%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 17.44 Million AUD | 67.0% |
| 2022 | 10.44 Million AUD | 311.42% |
| 2021 | 2.53 Million AUD | 15.04% |
| 2020 | 2.2 Million AUD | 3.57% |
| 2019 | 2.13 Million AUD | 23.23% |
| 2018 | 1.72 Million AUD | 400.6% |
| 2017 | 345.43 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 22.14 Million AUD | 0.0% |
| 2023 Q2 | 13.1 Million AUD | 0.0% |
| 2023 Q4 | 17.44 Million AUD | 0.0% |
| 2023 FY | 17.44 Million AUD | 67.0% |
| 2022 Q4 | 10.44 Million AUD | 0.0% |
| 2022 FY | 10.44 Million AUD | 311.42% |
| 2022 Q2 | 2.56 Million AUD | 0.0% |
| 2021 FY | 2.53 Million AUD | 15.04% |
| 2021 Q4 | 2.53 Million AUD | 0.0% |
| 2021 Q2 | 1.69 Million AUD | 0.0% |
| 2020 FY | 2.2 Million AUD | 3.57% |
| 2020 Q4 | 2.2 Million AUD | 0.0% |
| 2020 Q2 | 3.07 Million AUD | 0.0% |
| 2019 Q2 | 1.8 Million AUD | 0.0% |
| 2019 Q4 | 2.13 Million AUD | 0.0% |
| 2019 FY | 2.13 Million AUD | 23.23% |
| 2018 Q4 | 1.72 Million AUD | 0.0% |
| 2018 FY | 1.72 Million AUD | 400.6% |
| 2018 Q2 | 364.68 Thousand AUD | 0.0% |
| 2017 Q4 | 345.43 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | 345.43 Thousand AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -13984.905% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | -208.57% |
| Biome Australia Limited | 1.3 Million AUD | -1236.046% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -2429.386% |
| Imugene Limited | 1.54 Million AUD | -1027.72% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | -1467.678% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -5178.59% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -5413.678% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.904% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -1882.873% |
| Starpharma Holdings Limited | 3.52 Million AUD | -394.473% |
| Nanollose Limited | 42.53 Thousand AUD | -40918.105% |
| Memphasys Limited | 4.41 Million AUD | -295.294% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | -1017.038% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -4034.2% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Dimerix Limited | 149.68 Thousand AUD | -11554.63% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | -1320.293% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -10868.594% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | -1073.167% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -244570.407% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | -599.322% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -73844.557% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -7189.099% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -2050.544% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -9859.977% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -5367.469% |
| Immuron Limited | 173.49 Thousand AUD | -9954.929% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |